Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CRISPR/Cas9: implication for modeling and therapy of amyotrophic lateral sclerosis

6 Jul 2023

Abstract excerpt

Amyotrophic lateral sclerosis (ALS) is a deadly neurological disease with a complicated and variable pathophysiology yet to be fully understood. There is currently no effective treatment available to either slow or terminate it. However, recent advances in ALS genomics have linked genes to phenotypes, encouraging the creation of novel therapeutic approaches and giving researchers more tools to create efficient...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyotrophic Lateral Sclerosis Research
Share to CRISPR and Genetic Engineering
Share to Prion Diseases and Protein Misfolding

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37483353
DOI: 10.3389/fnins.2023.1223777

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CRISPR/Cas9: implication for modeling and therapy of amyotrophic lateral sclerosisPMID 37483353Read ↗

CRISPR/Cas9 Technology as an Emerging Tool for Targeting Amyotrophic Lateral Sclerosis (ALS)Semantic proximity Read ↗

In vivo genome editing improves motor function and extends survival in a mouse model of ALS.Semantic proximity Read ↗

A streamlined CRISPR workflow to introduce mutations and generate isogenic iPSCs for modeling amyotrophic lateral sclerosis.Semantic proximity Read ↗

A streamlined CRISPR workflow to introduce mutations and generate isogenic iPSCs for modeling amyotrophic lateral sclerosisSemantic proximity Read ↗

Efficacy and long-term safety of CRISPR/Cas9 genome editing in the SOD1-linked mouse models of ALSSemantic proximity Read ↗

Gene Targeted Therapies for Neurodegenerative Disorders: Strategies and Implications in ALS and SMASemantic proximity Read ↗

Gene therapy breakthroughs in ALS: a beacon of hope for 20% of ALS patientsSemantic proximity Read ↗

Mouse models of ALS: Past, present and future.Semantic proximity Read ↗

Advancements in CRISPR-Based Therapies for Genetic Modulation in Neurodegenerative Disorders.Semantic proximity Read ↗

Genetic architecture of amyotrophic lateral sclerosis: a comprehensive review.Semantic proximity Read ↗

Progress in Amyotrophic Lateral Sclerosis Gene DiscoverySemantic proximity Read ↗

Recent progress of the genetics of amyotrophic lateral sclerosis and challenges of gene therapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.